Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
SNTI | D | Senti Biosciences, Inc. | -16.67 | |
IBRX | D | ImmunityBio, Inc. | 1.62 | |
CGEM | D | Cullinan Management, Inc. | 2.88 | |
NBTX | D | Nanobiotix S.A. | 2.96 | |
AVTX | F | Avalo Therapeutics, Inc. | -5.06 | |
PDSB | F | PDS Biotechnology Corporation | 2.03 | |
CNCR | F | Loncar Cancer Immunotherapy ETF | 0.50 | |
IMNM | F | Immunome, Inc. | 3.59 | |
ZYME | F | Zymeworks Inc. | -0.12 | |
EVAX | F | Evaxion Biotech A/S | 8.62 |
Related Industries: Biotechnology Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 2.85 | |
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 2.01 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.52 | |
FDM | C | First Trust DJ Select MicroCap ETF | 1.33 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.04 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles